Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HLA DQ antibody (PE,Cy5.5)

The Mouse Monoclonal anti-HLA DQ antibody has been validated for FACS. It is suitable to detect HLA DQ in samples from Human.
Catalog No. ABIN7670251

Quick Overview for HLA DQ antibody (PE,Cy5.5) (ABIN7670251)

Target

HLA DQ (HLA-DQ) (MHC Class II HLA-DQ (HLA-DQ))

Reactivity

  • 49
  • 34
  • 2
Human

Host

  • 38
  • 13
Mouse

Clonality

  • 51
Monoclonal

Conjugate

  • 21
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HLA DQ antibody is conjugated to PE,Cy5.5

Application

  • 41
  • 32
  • 13
  • 12
  • 10
  • 8
  • 4
  • 3
  • 2
Flow Cytometry (FACS)

Clone

1a3
  • Purpose

    PE/Cyanine5.5 Anti-Human HLA-DQ Antibody[1a3]

    Immunogen

    E-AB-F09802I

    Isotype

    IgG2a, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    5 μL/tests

    Buffer

    Phosphate buffered solution, pH 7.2, containing 0.09 % stabilizer and 1 % protein protectant

    Handling Advice

    Please protected from prolonged exposure to light and do not freeze.

    Storage

    4 °C

    Storage Comment

    This product can be stored at 2-8°C for 12 months.

    Expiry Date

    12 months
  • Target

    HLA DQ (HLA-DQ) (MHC Class II HLA-DQ (HLA-DQ))

    Alternative Name

    HLA-DQ

    Background

    MHC class II DQ monomorphic antigen,MHC II,HLA-DQ is also known as MHC class II DQ monomorphic antigen. The major histocompatibility complex is composed of two heterodimeric glycoproteins (α and β chains) with apparent molecular weights of 27 and 32 kD. In contrast to other MHC class II molecules, both polypeptide chains of HLA-DQ are polymorphic, with the α chain showing an extremely high degree of polymorphism. HLA-DQ is expressed on B cells in the peripheral blood, and weakly expressed on activated T cells and some monocytes. HLA-DQ is absent on hematopoietic progenitors, resting T cells, erythrocytes, and platelets. HLA-DQ is expressed after HLA-DR and HLA-DP in hematopoietic development. HLA-DQ presents peptide fragments mainly from degraded intravesicular and extracellular proteins to CD4+ T lymphocytes. Specific alleles of HLA-DQ have been linked to the pathogenesis of several autoimmune diseases (including diabetes), both as a susceptibility and resistance factor depending on the particular polymorphism.

    UniProt

    P01906
You are here:
Chat with us!